PMD Act

Overview

The PMD Act is Japan’s main law for securing the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics, medical devices, in vitro diagnostics, regenerative medicine products and related regulated products. The full English title is the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices.

For import practice, the PMD Act becomes important when a product brought into Japan may fall within a regulated health, beauty, diagnostic, therapeutic or body-function category. A product may look like a food, supplement, cosmetic, device or general consumer good, but its ingredients, intended use, labeling, advertising claims and sales purpose may bring it within the scope of the PMD Act.

Detailed information on each product category is covered in separate articles on Cosmetics, Quasi-Drugs, Medical Devices, In Vitro Diagnostics, Health Foods and Medicinal Claims.

Why the PMD Act Matters in Import Practice

The PMD Act regulates not only manufacturing and sale, but also import, market placement, labeling, advertising, quality control and safety management for regulated products. For business import, the key issue is not only whether the cargo can clear customs, but whether the product can legally be placed on the Japanese market.

In practical terms, the importer must confirm the correct product category before sale. A product may require a licence, registration, notification, certification or approval depending on whether it is treated as a pharmaceutical, quasi-drug, cosmetic, medical device, in vitro diagnostic, regenerative medicine product or another regulated product.

Products Commonly Affected

PMD Act issues often arise in products connected with health, beauty, hygiene, diagnosis, treatment, prevention or body function. The following categories should be checked carefully before shipment or sale in Japan.

• Pharmaceuticals and pharmaceutical ingredients
• Quasi-drugs and medicated personal care products
• Cosmetics and skincare products
• Health foods and dietary supplements with strong health-related claims
• Medical devices and healthcare devices
• In vitro diagnostics and testing-related products
• Regenerative medicine products
• Beauty devices, wellness devices and measuring devices
• Products promoted with medicinal, therapeutic or body-function claims

Main Points to Check

• What is the intended product category in Japan?
• Does the product contain ingredients regulated in Japan?
• Does the product claim diagnosis, treatment, prevention or improvement of disease?
• Does it claim an effect on the structure or function of the human body?
• Is the product being imported for personal use or business use?
• Is a Japan-side licence, registration, notification, certification or approval required?
• Are labeling, manuals, EC pages, advertisements and social media content suitable for Japan?
• Does the overseas product description conflict with the intended Japanese regulatory treatment?

Relationship with Food Sanitation Act

The Food Sanitation Act mainly concerns the safety of foods, additives, utensils, containers and packaging. The PMD Act, by contrast, focuses on products connected with pharmaceuticals, cosmetics, medical devices, efficacy claims, body functions and medical or health-related purposes.

For this reason, a product cannot always be assessed only under food import rules. Health foods, supplements, beauty products, hygiene products, testing goods and wellness devices may require PMD Act confirmation even where the product is also relevant to food or consumer product regulation.

Medicinal Claims and Advertising

Under Japanese practice, ingredients and product form are important, but labeling and advertising are also critical. A food, supplement, cosmetic or general good may create PMD Act issues if it is promoted with medicinal or pharmaceutical-style claims.

Expressions suggesting that a product cures disease, improves symptoms, prevents illness, lowers blood pressure, improves immunity or affects body functions should be reviewed carefully. The overall advertising impression may matter, including testimonials, before-and-after images, expert comments, charts, research references and translated overseas marketing copy.

Personal Import and Business Import

Personal import and business import should be clearly distinguished. A product imported by an individual for personal use is different from a product imported for sale, resale, EC distribution, advertising, demonstration, clinic use or other business purposes.

However, personal import does not automatically remove all regulatory concerns. Quantity limits, product restrictions or other conditions may still apply. If the product is connected with commercial distribution or promotion in Japan, it should be treated as a business import issue and checked before shipment or market launch.

Common Problems

• The overseas supplier assumes that the product can be sold in Japan because it is sold freely abroad.
• The invoice describes the product as food, cosmetic or general goods, while the sales page suggests medicinal effects.
• Overseas advertising copy is translated directly into Japanese without PMD Act review.
• A beauty or wellness device is marketed with body-function or therapeutic claims.
• A supplement or health food is promoted with disease-related wording.
• The importer checks customs clearance but not the Japan-side licence, registration or approval requirements.
• Product labels, manuals, catalogues and EC pages create inconsistent regulatory impressions.

Practical Notes for Shipments to Japan

For shipments to Japan, overseas suppliers and origin-side forwarders should not decide the regulatory position based only on the invoice description, HS code or overseas sales category. The Japanese importer should confirm the product category, ingredients, intended use, labeling, advertising and sales route before shipment.

This is especially important for products that sit near the boundary between food, cosmetics, quasi-drugs, pharmaceuticals, medical devices, in vitro diagnostics and general consumer goods. Japanese practice may be conservative, and the same product may require a different regulatory approach in Japan compared with the country of origin.

Direct translation of overseas product descriptions is a common source of trouble. Expressions that are acceptable abroad may create medicinal claim, cosmetic claim, quasi-drug or medical device issues in Japan.

Relationship with Logistics and Customs

Forwarders and customs brokers are not expected to make final PMD Act classification decisions. However, they should notice warning signs and ask the importer to confirm the regulatory position when the cargo involves health, beauty, medicine, diagnostics, testing, body function or medical-style use.

For logistics practice, this is partly a document-control issue. The invoice, packing list, product label, manual, brochure, EC page and advertising material should not create conflicting impressions. If shipping documents describe the product as a general good but sales materials suggest medical, medicinal or quasi-drug effects, the importer should confirm the PMD Act position.

Key Takeaway

The PMD Act is a central law for import and sales practice involving pharmaceuticals, quasi-drugs, cosmetics, medical devices, in vitro diagnostics, regenerative medicine products and health-related products in Japan. Importers and logistics parties should not rely only on the product name or overseas category. Ingredients, intended use, labeling, advertising claims, sales purpose and Japan-side licences or procedures should be checked before shipment and market launch.